Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lotti

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Journal of Biological Regulators and Homeostatic Agents|July 14, 2017
Bi-layered collagen nano-structured membrane prototype collagen matrix 10826® for soft tissue regeneration in rabbits: an in vivo ultra-structural study of the early healing phaseD De Santis, G B Menchini Fabris, J Lotti, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066B V Clineschmidt, D J Pettibone, V J Lotti, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonistP K Siegl, R S Chang, N B Mantlo, et al.
Journal of Medicinal Chemistry|December 1, 1985
N-(1,3,4,6,7,12b-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin -2-yl)-N- methyl-2-hydroxyethane-sulfonamide: a potent and selective alpha 2-adrenoceptor antagonistJ R Huff, P S Anderson, J J Baldwin, et al.
Journal of Biological Regulators and Homeostatic Agents|July 14, 2017
Treatment of skin defects with growth factors and biodegradable collagen carrier: histological evaluation in animal modelP F Nocini, G B Menchini Fabris, F Gelpi, et al.
Journal of Medicinal Chemistry|November 25, 1994
A highly potent, orally active imidazo[4,5-b]pyridine biphenylacylsulfonamide (MK-996; L-159,282): a new AT1-selective angiotensin II receptor antagonistP K Chakravarty, E M Naylor, A Chen, et al.
Journal of Medicinal Chemistry|December 1, 1983
Pyridinylpiperazines, a new class of selective alpha 2-adrenoceptor antagonistsW S Saari, W Halczenko, S W King, et al.
The American Journal of Physiology|March 11, 1995
Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin IIS D Kivlighn, W R Huckle, G J Zingaro, et al.
European Journal of Pharmacology|December 29, 1995
In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptorsR S Chang, V J Lotti, T B Chen, et al.
Journal of Medicinal Chemistry|August 20, 1993
Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinonesL L Chang, W T Ashton, K L Flanagan, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Journal of Biological Regulators and Homeostatic Agents|July 14, 2017
Bi-layered collagen nano-structured membrane prototype collagen matrix 10826® for soft tissue regeneration in rabbits: an in vivo ultra-structural study of the early healing phaseD De Santis, G B Menchini Fabris, J Lotti, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066B V Clineschmidt, D J Pettibone, V J Lotti, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonistP K Siegl, R S Chang, N B Mantlo, et al.
Journal of Medicinal Chemistry|December 1, 1985
N-(1,3,4,6,7,12b-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin -2-yl)-N- methyl-2-hydroxyethane-sulfonamide: a potent and selective alpha 2-adrenoceptor antagonistJ R Huff, P S Anderson, J J Baldwin, et al.
Journal of Biological Regulators and Homeostatic Agents|July 14, 2017
Treatment of skin defects with growth factors and biodegradable collagen carrier: histological evaluation in animal modelP F Nocini, G B Menchini Fabris, F Gelpi, et al.
Journal of Medicinal Chemistry|November 25, 1994
A highly potent, orally active imidazo[4,5-b]pyridine biphenylacylsulfonamide (MK-996; L-159,282): a new AT1-selective angiotensin II receptor antagonistP K Chakravarty, E M Naylor, A Chen, et al.
Journal of Medicinal Chemistry|December 1, 1983
Pyridinylpiperazines, a new class of selective alpha 2-adrenoceptor antagonistsW S Saari, W Halczenko, S W King, et al.
The American Journal of Physiology|March 11, 1995
Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin IIS D Kivlighn, W R Huckle, G J Zingaro, et al.
European Journal of Pharmacology|December 29, 1995
In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptorsR S Chang, V J Lotti, T B Chen, et al.
Journal of Medicinal Chemistry|August 20, 1993
Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinonesL L Chang, W T Ashton, K L Flanagan, et al.
Pageof 13